Ngā hua rapu kaituhi

1

Phosphate Metabolism in CKD Stages 3–5: Dietary and Pharmacological Control mā Ketteler, Markus

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

14. Recent Approaches to Therapy: Is There Real Progress? mā Ketteler, Markus

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease mā Ketteler, Markus, Ambühl, Patrice

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future mā Brandenburg, Vincent, Ketteler, Markus

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

Evolving Calciphylaxis—What Randomized, Controlled Trials Can Contribute to the Capture of Rare Diseases mā Ketteler, Markus, Biggar, Patrick H.

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

Magnesium basics mā Jahnen-Dechent, Wilhelm, Ketteler, Markus

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

K-alcification Protection in Dialysis Patients: The Underestimated Phenomenon of Vitamin K Deficiency mā Ketteler, Markus, Brandenburg, Vincent Matthias

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease mā Fouque, Denis, Vervloet, Marc, Ketteler, Markus

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

Management of hyperphosphataemia in chronic kidney disease—challenges and solutions mā Ketteler, Markus, Wüthrich, Rudolf P., Floege, Jürgen

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

The Phosphorus and the Vascular Calcification in ESRD between Old Adventures and New Horizons mā Di Iorio, Biagio Raffaele, Ketteler, Markus, Russo, Domenico, Wang, Angela

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Atypical case of AL amyloidosis with urinary erythrocyte casts mā Liangos, Orfeas, Buettner-Herold, Maike, Ketteler, Markus, Madias, Nicolaos E.

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

Phosphate Additives in Food—a Health Risk mā Ritz, Eberhard, Hahn, Kai, Ketteler, Markus, Kuhlmann, Martin K, Mann, Johannes

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

Enhanced Oxidative DNA-Damage in Peritoneal Dialysis Patients via the TXNIP/TRX Axis mā Oberacker, Tina, Fritz, Peter, Schanz, Moritz, Alscher, Mark Dominik, Ketteler, Markus, Schricker, Severin

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients – Data... mā Rothe, Hansjörg, Brandenburg, Vincent, Haun, Margot, Kollerits, Barbara, Kronenberg, Florian, Ketteler, Markus, Wanner, Christoph

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

Association Between Human Fetuin-A and the Metabolic Syndrome Data From the Heart and Soul Study mā Ix, Joachim H., Shlipak, Michael G., Brandenburg, Vincent M., Ali, Sadia, Ketteler, Markus, Whooley, Mary A.

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide mā Covic, Adrian C., Floege, Jürgen, Ketteler, Markus, Sprague, Stuart M., Lisk, Laura, Rakov, Viatcheslav, Rastogi, Anjay

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation mā Floege, Jürgen, Funk, Felix, Ketteler, Markus, Rastogi, Anjay, Walpen, Sebastian, Covic, Adrian C, Sprague, Stuart M

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study mā Covic, Adrian C., Sprague, Stuart M., Rastogi, Anjay, Ketteler, Markus, Walpen, Sebastian, Perrin, Amandine, Floege, Jürgen

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

Association of Fetuin-A With Mitral Annular Calcification and Aortic Stenosis Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study mā Ix, Joachim H., Chertow, Glenn M., Shlipak, Michael G., Brandenburg, Vincent M., Ketteler, Markus, Whooley, Mary A.

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

Fetuin-A and kidney function in persons with coronary artery disease—data from the heart and soul study mā Ix, Joachim H., Chertow, Glenn M., Shlipak, Michael G., Brandenburg, Vincent M., Ketteler, Markus, Whooley, Mary A.

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Ketteler, Markus

Phosphate Metabolism in CKD Stages 3–5: Dietary and Pharmacological Control mā Ketteler, Markus

14. Recent Approaches to Therapy: Is There Real Progress? mā Ketteler, Markus

Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease mā Ketteler, Markus, Ambühl, Patrice

Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future mā Brandenburg, Vincent, Ketteler, Markus

Evolving Calciphylaxis—What Randomized, Controlled Trials Can Contribute to the Capture of Rare Diseases mā Ketteler, Markus, Biggar, Patrick H.

Magnesium basics mā Jahnen-Dechent, Wilhelm, Ketteler, Markus

K-alcification Protection in Dialysis Patients: The Underestimated Phenomenon of Vitamin K Deficiency mā Ketteler, Markus, Brandenburg, Vincent Matthias

Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease mā Fouque, Denis, Vervloet, Marc, Ketteler, Markus

Management of hyperphosphataemia in chronic kidney disease—challenges and solutions mā Ketteler, Markus, Wüthrich, Rudolf P., Floege, Jürgen

The Phosphorus and the Vascular Calcification in ESRD between Old Adventures and New Horizons mā Di Iorio, Biagio Raffaele, Ketteler, Markus, Russo, Domenico, Wang, Angela

Atypical case of AL amyloidosis with urinary erythrocyte casts mā Liangos, Orfeas, Buettner-Herold, Maike, Ketteler, Markus, Madias, Nicolaos E.

Phosphate Additives in Food—a Health Risk mā Ritz, Eberhard, Hahn, Kai, Ketteler, Markus, Kuhlmann, Martin K, Mann, Johannes

Enhanced Oxidative DNA-Damage in Peritoneal Dialysis Patients via the TXNIP/TRX Axis mā Oberacker, Tina, Fritz, Peter, Schanz, Moritz, Alscher, Mark Dominik, Ketteler, Markus, Schricker, Severin

Association Between Human Fetuin-A and the Metabolic Syndrome Data From the Heart and Soul Study mā Ix, Joachim H., Shlipak, Michael G., Brandenburg, Vincent M., Ali, Sadia, Ketteler, Markus, Whooley, Mary A.

Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide mā Covic, Adrian C., Floege, Jürgen, Ketteler, Markus, Sprague, Stuart M., Lisk, Laura, Rakov, Viatcheslav, Rastogi, Anjay

Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation mā Floege, Jürgen, Funk, Felix, Ketteler, Markus, Rastogi, Anjay, Walpen, Sebastian, Covic, Adrian C, Sprague, Stuart M

Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study mā Covic, Adrian C., Sprague, Stuart M., Rastogi, Anjay, Ketteler, Markus, Walpen, Sebastian, Perrin, Amandine, Floege, Jürgen

Association of Fetuin-A With Mitral Annular Calcification and Aortic Stenosis Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study mā Ix, Joachim H., Chertow, Glenn M., Shlipak, Michael G., Brandenburg, Vincent M., Ketteler, Markus, Whooley, Mary A.

Fetuin-A and kidney function in persons with coronary artery disease—data from the heart and soul study mā Ix, Joachim H., Chertow, Glenn M., Shlipak, Michael G., Brandenburg, Vincent M., Ketteler, Markus, Whooley, Mary A.

Ngā utauta rapu: